Stephane Oudard

Summary

Publications

  1. ncbi [New targeted therapies in hormone-refractory prostate cancer]
    Stephane Oudard
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris
    Bull Cancer 94:F62-8. 2007
  2. ncbi [Chemotherapy for prostate cancer]
    Jacques Medioni
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, F 75015 Paris, France
    Presse Med 37:814-20. 2008
  3. ncbi [Prostate cancer: update]
    Stephane Oudard
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris
    Bull Cancer 92:865-73. 2005
  4. doi [Prostate cancer and chemotherapy: standards care and perspectives]
    Yacine Hadjarab
    Hopital Europeen Georges Pompidou, Departement de cancerologie medicale, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 99:S46-56. 2012
  5. ncbi [Chemotherapy: principles and practice]
    Stephane Oudard
    Hopital Europeen Georges Pompidou, Departement de cancerologie medicale, 20 rue Leblanc Paris 75015, France
    Prog Urol 12:19-30. 2002
  6. doi Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit
    Stephane Oudard
    Department of Medical Oncology, Hopital Europeen Georges Pompidou, AP HP, René Descartes University Paris 5, 20 rue Leblanc, 75015 Paris, France
    Cancer Treat Rev 38:981-7. 2012
  7. doi [Renal carcinoma: point on treatment of brain metastasis]
    Corine Teghom
    Hopital Europeen Georges Pompidou, Service de cancérologie médicale, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 99:627-34. 2012
  8. doi [Experimental program personalized care in patients with head and neck cancer]
    Stephane Hans
    APHP, Hopital Europeen Georges Pompidou, Service d ORL, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 101:910-5. 2014

Collaborators

Detail Information

Publications8

  1. ncbi [New targeted therapies in hormone-refractory prostate cancer]
    Stephane Oudard
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris
    Bull Cancer 94:F62-8. 2007
    ....
  2. ncbi [Chemotherapy for prostate cancer]
    Jacques Medioni
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, F 75015 Paris, France
    Presse Med 37:814-20. 2008
    ....
  3. ncbi [Prostate cancer: update]
    Stephane Oudard
    Departement de cancerologie medicale, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75015 Paris
    Bull Cancer 92:865-73. 2005
    ..Studies in association with docetaxel are ongoing. Some biological responses were observed with a vaccine anti MUC-1 and must be confirmed on a greater series of patients. The docetaxel impact on localized disease is actually evaluated...
  4. doi [Prostate cancer and chemotherapy: standards care and perspectives]
    Yacine Hadjarab
    Hopital Europeen Georges Pompidou, Departement de cancerologie medicale, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 99:S46-56. 2012
    ..Docetaxel activity was also studied in early stage of prostate cancer and seems to be promising. A cabazitaxel activity in early stage of cancer is also being evaluated...
  5. ncbi [Chemotherapy: principles and practice]
    Stephane Oudard
    Hopital Europeen Georges Pompidou, Departement de cancerologie medicale, 20 rue Leblanc Paris 75015, France
    Prog Urol 12:19-30. 2002
  6. doi Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit
    Stephane Oudard
    Department of Medical Oncology, Hopital Europeen Georges Pompidou, AP HP, René Descartes University Paris 5, 20 rue Leblanc, 75015 Paris, France
    Cancer Treat Rev 38:981-7. 2012
    ..This review discusses and evaluates current clinical evidence for sequential therapy with targeted agents in patients with mRCC...
  7. doi [Renal carcinoma: point on treatment of brain metastasis]
    Corine Teghom
    Hopital Europeen Georges Pompidou, Service de cancérologie médicale, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 99:627-34. 2012
    ..The present revue aims to do a point on treatment of brain metastasis from renal carcinoma. It will address both locoregional (surgery, radiotherapy and stereotactic radiosurgery) and systemic (targeted therapies) treatments...
  8. doi [Experimental program personalized care in patients with head and neck cancer]
    Stephane Hans
    APHP, Hopital Europeen Georges Pompidou, Service d ORL, 20, rue Leblanc, 75015 Paris, France
    Bull Cancer 101:910-5. 2014
    ..Describe the implementation and preliminary results of the “Experimental Program Personalized care” in patients with Head and Neck cancer...